Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics

06 October 2020 : Database Analysis

Honggang Ke^1CD, Yunyu Wu^2DEF, Runjie Wang^3CDF, Xiaohong Wu^4AB*

DOI: 10.12659/MSM.925833

Med Sci Monit 2020; 26:e925833

Related articles Order reprints Share article Share by email

View HTML version

Table 7 Prognostic time for different risk classification models of the TCGA and GSE37745 dataset.

		Overall survival time (months, mean±SD)		Recurrence-free survival time (months, mean±SD)
		Low-risk	High-risk	Low-risk	High-risk
TCGA	Gene expression model	33.64±37.17	21.41±17.71	28.18±35.04	15.79±13.97
	Clinic factor model	29.03±35.46	27.01±27.76	25.74±32.68	19.32±22.79
	Combined model	33.55±40.09	22.33±17.78	28.33±35.87	16.31±14.57
GSE37745	Gene expression model	68.66±47.08	53.69±52.46	70.53±57.47	37.06±43.82
	Clinic factor model	84.51±62.38	54.51±50.67	62.53±55.77	30.66±39.29
	Combined model	84.50±62.38	54.51±50.69	62.53±55.77	30.66±39.29
TCGA – The Cancer Genome Atlas.

Back to the Article